TOP STORIES

Top 3 Undervalued Cannabis Royalty & Streaming Cannabis Companies

Cannabis streaming and royalty companies give investors a chance he risko invest in multiple companies within the cannabis sector that they would not have access to otherwise. There are similarities and differences between the two models that will be outlined in this piece.

Read More


The 7th Most Populated US State Is Moving Towards Cannabis Legalization

Ohio, the 7th most populated US state 11.66 million people is taking steps in legalizing cannabis. The Ohio Marijuana Legalization Initiative may appear on the ballot in Ohio as an initiated constitutional amendment as early as Q4 of 2018. The measure would legalize the use, possession, and sale of marijuana for persons age 21 or older in Ohio. In the meantime, medical dispensary and processing licenses are being awarded to a select group of companies.

Read More


S3 Report: The High Cost of Shorting Cannabis Stocks

A recent S3 study shows that cannabis short sellers have had a rough couple of months, down $626 million the report says. Tilray (TLRY.Q) and Canopy (WEED.T) shorters are the deepest in the water.

Read More


Is This the Start Of Aurora’s Next Bull Run? Coca Cola Looks Into CBD Drinks

This morning it was reported that Coca Cola (KO.N) is in serious talks with Aurora Cannabis to develop a CBD based drink.  According to BNN,  Coca Cola and Aurora (ACB.T) would likely develop beverages that will ease inflammation, pain and cramping. It's highly likely that Coca Cola are in talks with multiple cannabis companies.

Read More


A Closer Look Into the Weird World of Sean Dollinger & Namaste Technologies

It's been a rough week for Namaste Technologies (N.V) after Tilray backed out their deal with the company on Friday when a shareholder pledge party broke a couple of laws laid out in the Cannabis Act. The general sentiment from Namaste shareholders was that the pledge party was a pretty stupid idea, one that they paid for. This is Namaste's CEO Sean Dollinger's first run at a pubco, and he has made some pretty large blunders thus far.

Read More


The Hype Is Huge On Canopy Rivers IPO This Week

Canopy Rivers (RIV) is the venture arm of Canopy Growth (WEED.T) set to go public this week. The IPO price back in June was $3.50. But, based on market changes since then, on opening day, it could be as high as $5.00. Many investors will be lined up aftering watching what happened recently after the Tilray (TLRY.Q), Charlott'es Web (CWEB.C)  and Martello Technologies (MTLO.C) IPO.

Read More


Top 5 News Stories In Cannabis This Week (September 14th/2018)

The market jumped on the buying opportunity this morning with over 48 million shares traded as of 2:45 PM EST. MTLO opened at $0.485 and closed at $1.11. Canopy has been one of the hottest cannabis stocks over the past few years and has gotten even more attention after a 5 billion dollar investment from Constellation Brands.

Read More


Canopy CEO’s New Tech Stock Is Up 152% Today

Yesterday Canopy Growth (WEED.T) CEO Bruce Linton went on BNN to talk about his involvement in the brand new tech stock Martello (MTLO.C). Shares of Martello, which now trades under the symbol MTLO, opened at $0.50 on Wednesday morning, giving the firm a valuation around $85.9 million. Martello completed an RTO of a Vancouver-based shell company to achieve its listing on the TSX Venture Exchange.

Read More


Charlotte’s Web & Tilray Both Have Insane Charts For the Same Reason

Ever since Tilray's IPO back in July the stock has gone absolutely nuts. On paper Tilray is a solid company compared to many other cannabis companies, but a PB/V North of 200 is crazy. With a current market cap of $9.6 billion, to say it's inflated is an understatement.

Read More


Supreme Is Still On Fire

Today Supreme (FIRE.C) announced a supply agreement with Tilray (TLRY.Q). The value of this initial supply agreement is estimated to be in excess of $2 million.  Dried cannabis provided to Tilray by Supreme subsidiary 7ACRES will be used primarily to support medical cannabis patients in Canada, including Tilray's robust patient population.

Read More


Is Aurora A Buy At These Prices, Or Have They Burnt Out?

Today Aurora (ACB.T) announced the acquisition of Uruguay based cannabis company ICC Labs (ICC.C). Aurora intends to acquire all of the issued and outstanding common shares of ICC for $1.95 per share equalling a purchase price of approximately $290 million.

Aurora will be getting a multitude of benefits from this deal and still their stock has only moved 0.7% as of 11:45 AM EST today.

Read More


Tilray’s Financial Ratios Make No Sense; Why This Is the Most Overvalued Cannabis Stock

Yesterday Citron Research announced that it was shorting Tilray, naming it the most expensive stock in the cannabis space. Last week Citron came out stating an aggressive short position against Cronos which we wrote two articles about.

Read More


Do You Even SEDAR? The Beginners Guide to Actually Researching Stocks (With Photos)

SEDAR and SEDI may be three of the worst designed sites on the internet, but they are crucial. This piece will focus mostly on SEDAR and how to find information on Canadian public companies.

Investor decks and press releases are useful, but these are carefully crafted marketing materials that companies use to put the absolute best sales pitch together. To dig deeper into what’s actually going on, a company’s MD&A and Financial reports are far more important. These are found on SEDAR. Whenever an a company insider sells stock, it will be recorded on SEDI.

Read More


UPDATE: Cronos Bouncing Back After Its Week In Hell

This morning Cronos (CRON.Q) shot out of the gate hitting a high of $13.42, up from $11.50 on the open, and is sitting at $12.68 with 12.2 million shares as of 1:42 PM EST.

Read More


HIKU Shareholders Approve The Canopy Deal, Stock will Cease Trading Friday

Today Hiku (HIKU.C) announced that their shareholders voted in favour of Canopy's acquisition of Hiku. This means that Hiku's stock will cease trading starting this Friday. The required shareholder approval thresholds were met

Read More


Cronos Plummets 28% As Infamous Shorters Release Vague Report

Today Citron Research came out with a vague shorting report on Cronos (CRON.N), giving them a price target of $3.50 . The market ate it up and Cronos dropped 28% on 22 million shares traded. Claiming Cronos is overvalued at this point is a valid argument.

Read More


Cannabis Companies Flooding Onto the NASDAQ: Cronos, Tilray & Namaste

Back in May 2018, Cronos (CRON.Q) became the first cannabis company to be listed on the NASDAQ. Earlier this week Tilray (TLRY.Q) also joined as the first cannabis company to do an IPO on the major US exchange. Tilray managed to raise $201.5 million USD on opening day.

Read More